Statements (36)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antiretroviral therapy |
| gptkbp:activeIngredient |
gptkb:elvitegravir
gptkb:cobicistat emtricitabine tenofovir disoproxil |
| gptkbp:approvalYear |
2012
|
| gptkbp:associatedWith |
gptkb:Genvoya
|
| gptkbp:ATCCode |
gptkb:J05AR13
|
| gptkbp:CASNumber |
1391644-26-0
|
| gptkbp:contraindication |
severe liver impairment
concurrent use with certain drugs |
| gptkbp:drugClass |
protease inhibitor
fixed-dose combination pharmacokinetic enhancer |
| https://www.w3.org/2000/01/rdf-schema#label |
Stribild
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Gilead_Sciences
|
| gptkbp:marketedIn |
gptkb:Canada
gptkb:European_Union gptkb:United_States |
| gptkbp:onceDaily |
true
|
| gptkbp:pregnancyCategory |
gptkb:B3
B |
| gptkbp:prescriptionForm |
gptkb:tablet
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea fatigue headache abnormal dreams |
| gptkbp:usedFor |
HIV infection
|
| gptkbp:bfsParent |
gptkb:DB06151
gptkb:Tenofovir_Disoproxil_Fumarate gptkb:DB04876 |
| gptkbp:bfsLayer |
7
|